Pharma Stocks
-
Assessing Bayer (XTRA:BAYN) Valuation After Leadership Shift In U.S. Pharmaceuticals
Bayer’s leadership reshuffle in U.S. pharmaceuticals Bayer (XTRA:BAYN) has announced that Nelson Ambrogio will become President of Bayer U.S. Pharmaceuticals…
Read More » -
Piramal Pharma Ltd Sees Technical Momentum Shift Amid Mix…
Technical Trend Overview and Price Movement The stock closed at ₹143.90, up from the previous close of ₹141.05, marking a…
Read More » -
Why Terns Pharmaceuticals Stock Rocked the Market in March
Key Points All told, the transaction is valued at around $6.7 billion. If all goes well, it’ll close this quarter.…
Read More » -
Why this Japanese pharma gem deserves your attention now
In a crowded healthcare market, Hisamitsu Pharmaceutical stands out with its dominance in transdermal patches and global expansion push. You…
Read More » -
What investors should know about its steady pharma powerhouse status
As a global leader in innovative medicines, Novartis AG offers stability and growth potential in a volatile pharma sector. Whether…
Read More » -
Assessing InnoCare Pharma (SEHK:9969) Valuation After Its 2025 Profit Turnaround
Earnings shift draws fresh attention to InnoCare Pharma InnoCare Pharma (SEHK:9969) has drawn fresh attention after reporting full year 2025…
Read More » -
New Halozyme deal signals pipeline push
Vertex Pharmaceuticals just inked a key collaboration with Halozyme on advanced drug delivery tech, potentially boosting its pipeline for serious…
Read More » -
IQVIA.ai Launch With Nvidia Puts AI At Core Of Pharma Ties
IQVIA Holdings has launched IQVIA.ai, a unified AI platform built with Nvidia technology for the life sciences sector. The platform…
Read More » -
What you should know now before investing
You’re eyeing Japanese pharma plays—Santen Pharmaceutical stands out in ophthalmology with a focused pipeline and global reach that matters for…
Read More » -
Why this Japanese pharma gem deserves your attention now
Discover how Kyowa Kirin Co Ltd stands out in oncology and rare diseases with a robust pipeline that could drive…
Read More »